Humoral immunity is that aspect of specific immunity that is mediated by B lymphocytes and involves the neutralising of disease-producing microorganisms, called pathogens, by means of antibodies attaching to the pathogen's binding sites. This inhibits the pathogen's entry into target cells. We present a master equation in both discrete and in continuous form for a ligand bound at n sites becoming a ligand bound at m sites in a given interaction time.
Introduction
Antibodies bind to, and block, ligand sites on a pathogen (an infectious foreign agent) affecting its capacity to attach to target cell receptors. As a consequence, the ability of the pathogen to enter a target cell is inhibited. In addition, antigen-bound antibodies produce a signal that activates specific white blood cells, the macrophages, which then engulf and destroy the bound pathogen. Since viruses and many bacteria reproduce within cells, blocking the cell attachment would limit such pathogens from replicating. The time-dependent dissociation and recombination of complexes formed by antibodies attaching to the surface of ligands is a fundamental process in mathematical immunology in general, and in the study of humoral immunity, in particular, and is the topic of investigation in this paper. The aim here is to provide a novel way of estimating the time-evolution of the distribution of the specific number of bound antibodies (we track a cohort of pathogen-antibody aggregates).
Two approaches have been used to calculate the aggregate size distribution. The first approach, the obvious one, is to write down differential equations in the form of chemical rate equations for the concentrations of all possible ligand-receptor aggregates [3] . However, a complete description requires the solution of a large set of coupled ordinary differential equations [12] , one for each aggregate. While this system is straightforward to formulate, the order of the system is very large. For example, rat basophilic leukemia cells have approximately 10 5 receptors per cell and a chlamydial elementary body has approximately 2:86 × 10 4 receptors. If this approach is used to estimate a time-dependent aggregate distribution size the set of equations must be truncated [3, 14] . A second approach is less general, but can be used to obtain the complete time-dependent aggregate size distribution by solving just two coupled nonlinear differential equations [11] . The kinetics of the ligand-receptor complexes distribution are presented in the form of a series [10, 1] . Although this works well for relatively small numbers of binding sites (1-100), a simpler mathematical approximation would be very useful for a system when the number of binding sites is significantly greater [21] . Here we develop another approach to obtain the complete time-dependent aggregate size distribution for multivalent ligands (cell surfaces with many receptors) bound by molecules that bind at one receptor only. It involves solving a single diffusion equation. One example of such a binding molecule is the Fab fragment of an antibody, comprising one arm of the full Y-shaped antibody. While this restricts the model's applicability to antibody-pathogen interactions in general, there are many systems for which this assumption is appropriate. For example, the pent-valent adenovirus requires full occupancy by antibodies to achieve neutralisation. This can be achieved by Fabs but not by whole antibodies (IgG molecules in this case) [19] . A similar phenomenon has been found in antibody-Chlamydia interactions [20] . We also assume that all binding sites are equivalent and we assume that adsorbed particles do not interact, that is, the binding of a molecule at one site does not block the binding at a neighbouring site.
Our theory is similar to that used by Keck and Carrier [6] , who investigated techniques for solving master equations for the coupled vibration-dissociation-recombination process for molecules and atoms.
Modelling antibody attachment numbers on a pathogen
Consider a pathogen bound at n sites by antibodies. We assume that there is a probabilistically inferred rate at which the pathogen bound at n sites can become a pathogen bound at m sites. The discrete version of any such model is of the form
where A.n; t/ is the concentration of pathogens with n antibodies attached and N is the maximum number of antibodies that can be bound to a pathogen simultaneously. This equation states that pathogens bound by n antibodies may leave this state by making transitions to pathogens bound by m antibodies, gaining or losing antibodies, at a rate K .n; m/A.n; t/. We expect transitions from n antibodies to n − 1 or n + 1 antibodies on a pathogen to dominate the rate function, K . The discrete equation (2.1) for the dynamics of the pathogen-antibody concentrations has an analogous continuous version,
where k.x; x / is the probabilistically inferred rate of undergoing a transition from state x to state x per unit time and f is the maximum number of antibodies on average that can attach to the surface of the pathogen simultaneously.
In the absence of immune clearance and cell infection the pathogen-antibody concentrations, E.x; t/, have a non-trivial equilibrium distribution, which we denote by E e .x/. At equilibrium @ E.x; t/=@t is zero, and the requirement for detailed balancing [8] leads to the condition
We use the equilibrium distribution to introduce the non-dimensionalised concentration
which is the ratio of the concentration of pathogens with x antibodies attached to the associated equilibrium concentration. Then (2.2) can be written in the symmetrical form
Transformation to the diffusion equation
We now transform the master equation, (2.4), to an equivalent diffusion equation. The transformation assumes the integrand in (2.4) can be expanded in a Taylor series about x = x and we assume that the kernel, R.x; x /, is separable, and is large only for x ≈ x. We can then anticipate that the solution of (2.4) can be well approximated by the solution of
Expanding X .x ; t/ about x = x, we obtain the partial differential equation
where
is the nth moment of the change in antibody level .x − x/ with respect to R.x; x /. Observing symmetry of R.x; x / on interchange of x and x requires that R.x; x / = S.x; |1|/; wherex = .x +x/=2 is the mean of the initial and final antibody levels and 1 = x −x is the change in the antibody levels. Assuming S.x; |1|/ is sharply peaked at 1 = 0, we expand about 1 = 0 and obtain
and substituting (3.2) into (3.1) results in
a one-dimensional diffusion equation. The boundary conditions necessary to determine X .x; t/ uniquely are
since a pathogen cannot have a negative number of antibodies and will not have more than the maximum of f antibodies. We also require an initial condition which we define as X .x; 0/ = f 1 Ž.x/, x ≥ 0, where Ž.x/ is the Dirac delta function. Here we let there be an initial concentration of magnitude, f 1 , on the boundary at x = 0 and zero concentration for x > 0. This specifies that there are no attached antibodies initially. When we solve the diffusion equation numerically we let
We note that (3.3) can be written as
and thus there are two components indicating how the distribution will change with time, namely, X will diffuse in the direction of least antibodies, and will be balanced by what the equilibrium should be according to the probability distribution that influences the moment, ¼ 2 .
Probability distribution for change in the number of antibodies
To solve the diffusion equation we require a form for R.x; x /. Consider the quantum version of antibody-pathogen interactions. In a time characteristic of the interaction of an antibody with an antigen, of duration Ž t , a bound site may dissociate with probability q or remain bound with probability 1 − q. Here q is related to the antibody's dissociation constant, k D . Also, an antibody may attach to an unbound site with probability p or an unbound site may remain unbound with probability 1 − p. Here p is related to the antigen-antibody association rate, k A . Then, if v.i/ is an integer, it is straightforward to show that
where P.i; j / denotes the probability that a pathogen bound at i sites becomes a pathogen bound at j sites in one interaction time and Since 0.n + 1/ = n!, we take the analogous probability distribution for the approximate continuous distribution, namely,
where C.x; x / is the number of ways a pathogen bound at x sites can become a pathogen bound at x sites, and can be expressed as
An example of the probability distribution is illustrated in Figure 1 . Then k.x; x / = k 1 P.x; x /, where k 1 is a rate parameter that incorporates the interaction time Ž t . The equilibrium distribution, E e .x/, can now be determined by ensuring P.x ; x/E e .x / = P.x; x /E e .x/, leading to
Integrating both sides of (4.1) over the interval x = .0; f / and noting that because we are not considering any source or loss, the number of pathogens will remain at a 
FIGURE 2. Plots of the equilibrium distribution, E e .x/. We take f 1 = f = 100. (a) Binding probability low relative to dissociation probability ( p = 0:00005; q = 0:03). (b) Binding probability comparable to dissociation probability ( p = 0:005; q = 0:003). (c) Binding probability high relative to dissociation probability ( p = 0:05; q = 0:0003).
which is illustrated in Figure 2 for various probabilities, p and q.
In the limiting case as p → 0 (that is, antibodies do not attach to unbound sites because the antibody and ligand site are not complementary), E e .x/ = E 0 Ž.x/. Although the reaction of ligand-receptor binding is reversible, in particular cases of specific binding the dissociation reaction can be neglected [21] . Then in the limiting case as q → 0 (that is, irreversible binding), E e .x/ = E 0 Ž.x − f /.
Numerical solution
Given that we now have an expression for R.x; x /, an expression for the kernel of our diffusion equation can be determined. The magnitude of the kernel function varies considerably with the probabilities for binding and dissociation. This greatly influences the time for diffusion. We employ a fully implicit vertex-centred finite volume method [9] to obtain numerical solutions to the one-dimensional diffusion equation, (3.3) , and then use (2.3) to revert to the solution for E.x; t/, the concentration of pathogens with x antibodies attached at time t. Figures 3 and 4 illustrate the solutions for E at various times, for two different expressions of the kernel, ¼ 2 .x/, corresponding to relative medium and large probabilities of antibody attachment. We do not display the solution for E when the probability of antibody attachment is small because there is little change from the initial distribution.
Discussion
The humoral arm of the immune system is crucial in neutralising many infectious agents. The mechanisms by which humoral immunity is effective have been studied experimentally [15, 16, 2] and theoretically [18, 13, 17] . Humoral immunity is mediated by B lymphocytes through the release of antibodies specific for attachment to a pathogen's binding sites. Increasing the level of antibodies attached to a pathogen's surface binding sites inhibits cell infection and increases pathogen clearance. The central theoretical problem associated with the binding of multivalent ligands is to predict the aggregate size distribution, from which all quantities of interest can be calculated [12] . When comparing theory with experiment it is often important to know this distribution because some types of cells respond differently to different size aggregates. For example, small numbers of IgE antibodies are relatively ineffective at stimulating degranulation of rat basophilic leukemia cells (RBL) cells, whereas larger aggregates are quite effective [4] . Human basophil cells also display large sensitivity to aggregate size [7] . However, predicting the aggregate size distribution requires the solution of a very large number of coupled ordinary differential equations. We have presented the master equation for pathogen-antibody levels in discrete and classical forms and shown how the classical master equation can be transformed to an equivalent diffusion equation in a non-dimensional variable. Thus we have reduced a system of N (N usually very large) coupled ordinary differential equations to a diffusion equation. The diffusion equation is much easier to work with and the theory of such an equation is well known. We developed a probabilistically inferred rate of transition between antibody levels for the pathogen which influenced the nonconstant coefficient of the diffusion equation. We determined equilibrium distributions
